Sumitomo Chemical India earnings calls.

Sumitomo Chemical India reported a disappointing Q2 FY26 with revenue declining 5.9% YoY to Rs 930 croreCurrent reported value: 5.9% YoY to Rs 930 crore. No comparable prior figure is available in the source record. due to excessive monsoon rainfall that crippled field spray operations across the Kharif season. While H1 revenue grew 9% YoY to Rs 1,987 croreCurrent reported value: H1 revenue grew 9% YoY to Rs 1,987 crore. No comparable prior figure is available in the source record. and PAT rose 11% to Rs 356 croreCurrent reported value: 11% to Rs 356 crore. No comparable prior figure is available in the source record., Q2 volumes contracted meaningfully. Gross margin expanded 50bps to 43.1%Current reported value: 50bps to 43.1%. No comparable prior figure is available in the source record. demonstrating pricing discipline, though EBITDA margin compressed 140bps to 23.4%Current reported value: 140bps to 23.4%. No comparable prior figure is available in the source record. on lower operating leverage. The company maintained its channel health with negligible sales returns and no price cuts. Export revenue declined 4% YoYCurrent reported value: 4% YoY. No comparable prior figure is available in the source record. in H1 (South America down 33%) but management sees early stabilization signs globally. With reservoirs at full capacity and soil moisture adequate, management expects a strong Rabi recovery. The Rs 500-600 crore Dahej capexCurrent reported value: Rs 500-600 crore Dahej capex. No comparable prior figure is available in the source record. for 7 products remains on track, with 2 approvals received and 5 expected by FY26 year-end, targeting revenues from CY2028Current reported value: CY2028. No comparable prior figure is available in the source record..